Literature DB >> 5020937

Tumor-associated immunoglobulins. Enhancement of syngeneic tumors by IgG2-containing tumor eluates.

M Ran, I P Witz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5020937     DOI: 10.1002/ijc.2910090126

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  8 in total

1.  Tumour-bound immunoglobulins. The in vitro fixation of radioiodine-labelled anti-immunoglobulin reagents by tumour cells.

Authors:  I P Witz; S Kinamon; M Ran; G Klein
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

2.  Mechanisms by which tumors avoid destruction by the immune system BCG-catalyzed increase in IgG and IgA blocking activity of lymphocyte-mediated cytotoxicity.

Authors:  A A Hakim
Journal:  Klin Wochenschr       Date:  1975-09-15

Review 3.  Immune surveillance and natural resistance: an evaluation.

Authors:  W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 4.  B cell regulation in cancer and anti-tumor immunity.

Authors:  Anushruti Sarvaria; J Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2017-06-19       Impact factor: 11.530

5.  The tumor microenvironment: the making of a paradigm.

Authors:  Isaac P Witz
Journal:  Cancer Microenviron       Date:  2009-08-23

6.  Serological response to intracaecal injections of antigenic mouse tumour cells.

Authors:  M L Laursen
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

7.  Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.

Authors:  M L Laursen; K Laursen
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

8.  Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade.

Authors:  G R Flannery; P J Chalmers; J M Rolland; R C Nairn
Journal:  Br J Cancer       Date:  1973-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.